letters & comments

Congressional Efforts to Address Drug Pricing – Prescription Drug Pricing Reduction Act (PDPRA)

12/17/2019 Read More

Letter to Representatives DeGette & Upton on the “Cures 2.0” Initiative

12/16/2019 Read More

2020 Proposed Changes to Institute for Clinical and Economic Review’s (ICER) Framework

10/18/2019 Read More

2020 Revisions to Payment Policies under the Physician Fee Schedule and Other Changes to Part B Payment Policies

09/27/2019 Read More

Proposed Changes to the Medicare Outpatient Prospective Payment System and Ambulatory Surgical Center Payment System

09/27/2019 Read More

Value Assessment Methods for Single or Short-Term Transformative Therapies (SSTs)

09/06/2019 Read More

Centers for Medicare & Medicaid Services’ (CMS’) Request for Information: Reducing Administrative Burden to Put Patients over Paperwork

08/13/2019 Read More

Food and Drug Administration’s (FDA’s) Draft Guidance on Enhancing the Diversity of Clinical Trial Populations

08/06/2019 Read More

NHC’s Support of a Cap on Out-of-Pocket Costs for Medicare Part D

07/10/2019 Read More
1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19